Celularity Inc appointed Rick Gonzalez as Chief Commercial Officer effective May 29, 2026, to lead global commercialization of cenplacel-L and Lifebank. The appointment supports the company's revenue-generating strategy in the regenerative medicine market, leveraging Gonzalez's 20+ years of biotech and medtech executive experience.